Dr. Hamilton Discusses Trastuzumab deruxtecan - NBCLX
Trastuzumab Deruxtecan for HER2+ Breast Cancer
Trastuzumab deruxtecan: a promising agent for treating HER2-low breast cancer?
Dr. Peters Discusses Ongoing Research With Trastuzumab Deruxtecan in NSCLC
Trastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer. Specifically it is used for breast cancer that is HER2 receptor positive. It may be used by itself or together with other chemotherapy medication. Trastuzumab is given by slow injection into a vein and injection just under the skin.